45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
20,567
Insurances with rates
2
CPT / HCPCS codes
16,778
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J7181 | TRETTEN 2,500 UNIT INTRAVENOUS SOLUTION | $369,210 | $369,210 | — | — | 4 |
| J2326 | SPINRAZA (PF) 12 MG/5 ML INTRATHECAL SOLUTION | $333,562 | $333,562 | — | — | 2 |
| Q2043 | PROVENGE 50 MILLION CELL/250 ML INTRAVENOUS SUSPENSION | $289,537 | $289,537 | — | — | 2 |
| J0225 | AMVUTTRA 25 MG/0.5 ML SUBCUTANEOUS SYRINGE | $272,120 | $272,120 | — | — | 2 |
| J9347 | IMJUDO 20 MG/ML INTRAVENOUS SOLUTION | $269,803 | $269,803 | — | — | 4 |
| J2351 | OCREVUS ZUNOVO 920 MG-23,000 UNIT/23 ML SUBCUTANEOUS SOLUTION | $193,199 | $193,199 | — | — | 2 |
| J1823 | UPLIZNA 10 MG/ML INTRAVENOUS SOLUTION | $150,672 | $150,672 | — | — | 4 |
| 0915T | Insj Perm Ccm-D Sys Pg&Eltrd | $140,364 | $140,364 | — | — | 2 |
| J9999 | GLIADEL WAFER 7.7 MG IMPLANT | $131,789 | $131,789 | — | — | 2 |
| J2350 | OCREVUS 30 MG/ML INTRAVENOUS SOLUTION | $131,277 | $131,277 | — | — | 2 |
| 0408T | Insj/Rplc Car Modulj Sys Pls Gen Transvns Eltrd | $120,372 | $120,372 | — | — | 2 |
| J9226 | SUPPRELIN LA 50 MG (65 MCG/DAY) IMPLANT KIT | $114,414 | $114,414 | — | — | 2 |
| C2624 | Wireless Pressure Sensor | $101,590 | $101,590 | — | — | 2 |
| C9293 | VORAXAZE 1,000 UNIT INTRAVENOUS SOLUTION | $98,571 | $98,571 | — | — | 2 |
| 0916T | Insj Perm Ccm-D Sys Pg Only | $98,270 | $98,270 | — | — | 2 |
| 0923T | Rmvl&Rplcmt Perm Ccm-D Pg | $98,270 | $98,270 | — | — | 2 |
| J1628 | TREMFYA 200 MG/20 ML (10 MG/ML) INTRAVENOUS SOLUTION | $92,643 | $92,643 | — | — | 4 |
| Q4116 | ALLODERM THICK PERFERATED 1519320PBP | $83,799 | $83,799 | — | — | 2 |
| C9741 | Impl Pressure Sensor W/Angio | $83,696 | $83,696 | — | — | 2 |
| J9028 | ANKTIVA 400 MCG/0.4 ML INTRAVESICAL SOLUTION | $81,624 | $81,624 | — | — | 2 |
| 33270 | Insrtn Subq Implnt Defib Systm | $80,105 | $80,105 | — | — | 2 |
| J9269 | ELZONRIS 1,000 MCG/ML INTRAVENOUS SOLUTION | $76,965 | $76,965 | — | — | 2 |
| 33249 | Ins/Rpos Dual Chmb Pcg Lds&Gen | $76,808 | $76,808 | — | — | 2 |
| 93590 | Perq Transcath Cls Paravalvr Leak 1 Mitral Valve | $74,855 | $74,855 | — | — | 2 |
| 93591 | Perq Transcath Cls Paravalvr Leak 1 Aortic Valve | $74,855 | $74,855 | — | — | 2 |
| J2507 | KRYSTEXXA 8 MG/ML INTRAVENOUS SOLUTION | $72,477 | $72,477 | — | — | 2 |
| J9334 | VYVGART HYTRULO 1,000 MG-10,000 UNIT/5 ML SUBCUTANEOUS SYRINGE | $70,274 | $70,274 | — | — | 4 |
| C9767 | Fem/Pop Art Stent/Arthrect/Pta | $69,972 | $69,972 | — | — | 2 |
| J0202 | LEMTRADA 12 MG/1.2 ML INTRAVENOUS SOLUTION | $67,817 | $67,817 | — | — | 2 |
| J9345 | ZYNYZ 500 MG/20 ML INTRAVENOUS SOLUTION | $66,769 | $66,769 | — | — | 2 |
| J9359 | ZYNLONTA 10 MG INTRAVENOUS SOLUTION | $66,188 | $66,188 | — | — | 2 |
| J1246 | UNITUXIN 3.5 MG/ML INTRAVENOUS SOLUTION | $65,311 | $65,311 | — | — | 2 |
| J9316 | PHESGO 1,200 MG-600 MG-30,000 UNIT/15 ML SUBCUTANEOUS SOLUTION | $65,129 | $65,129 | — | — | 2 |
| J0222 | ONPATTRO 2 MG/ML INTRAVENOUS SOLUTION | $62,233 | $62,233 | — | — | 2 |
| J2267 | OMVOH 300 MG/15 ML (20 MG/ML) INTRAVENOUS SOLUTION | $61,013 | $61,013 | — | — | 2 |
| 93654 | Comp Ep Eval W/Ablation for V-Tach | $59,861 | $59,861 | — | — | 2 |
| 33262 | Rmvl Pcd W/Rplc Sngl Lead | $56,826 | $56,826 | — | — | 2 |
| J2323 | TYSABRI 300 MG/15 ML INTRAVENOUS SOLUTION | $56,472 | $56,472 | — | — | 2 |
| 33263 | Rmvl Pcd W/ Rplc Dual Lead | $56,396 | $56,396 | — | — | 2 |
| 33418 | Tcat Mitral Valve Repair Initial Prosthesis | $56,280 | $56,280 | — | — | 2 |
| 93583 | Perq Transcath Septal Reductn Tx | $56,144 | $56,144 | — | — | 2 |
| J9229 | BESPONSA 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) INTRAVENOUS SOLUTION | $55,619 | $55,619 | — | — | 2 |
| J2329 | BRIUMVI 25 MG/ML INTRAVENOUS SOLUTION | $55,374 | $55,374 | — | — | 2 |
| J9272 | JEMPERLI 50 MG/ML INTRAVENOUS SOLUTION | $54,483 | $54,483 | — | — | 2 |
| G2170 | Avf by Tissue W Thermal Energy | $54,422 | $54,422 | — | — | 2 |
| G2171 | Avf Use Magnetic/Art/Ven | $54,422 | $54,422 | — | — | 2 |
| J2327 | SKYRIZI 360 MG/2.4 ML (150 MG/ML) SUBCUTANEOUS WEARABLE INJECTOR | $54,352 | $54,352 | — | — | 4 |
| C2616 | Y90 Dose | $54,150 | $54,150 | — | — | 2 |
| J3316 | TRIPTODUR 22.5 MG IM SUSPENSION | $52,364 | $52,364 | — | — | 4 |
| C1767 | Generator, Neurostimulator(Imp) | $51,507 | $51,507 | — | — | 2 |
Showing top 50 of 20,567 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.